18-49378592-A-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001353214.3(DYM):c.396T>A(p.Tyr132*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,459,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001353214.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYM | NM_001353214.3 | c.396T>A | p.Tyr132* | stop_gained | 5/18 | ENST00000675505.1 | NP_001340143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYM | ENST00000675505.1 | c.396T>A | p.Tyr132* | stop_gained | 5/18 | NM_001353214.3 | ENSP00000501694.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250890Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135614
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459664Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726296
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2021 | The c.396T>A (p.Y132*) alteration, located in exon 5 (coding exon 4) of the DYM gene, consists of a T to A substitution at nucleotide position 396. This changes the amino acid from a tyrosine (Y) to a stop codon at amino acid position 132. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the A allele has an overall frequency of <0.01% (1/250890) total alleles studied. The highest observed frequency was 0.01% (1/16220) of African alleles. This alteration was confirmed to be compound heterozygous with a second alteration in a patient with Dyggve-Melchior-Clausen dysplasia (Cohn, 2003). Based on the available evidence, this alteration is classified as pathogenic. - |
Dyggve-Melchior-Clausen syndrome;C3888088:Smith-McCort dysplasia 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 29, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 15, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 3186). This premature translational stop signal has been observed in individual(s) with Dyggve-Melchior-Clausen syndrome (PMID: 12491225). This variant is present in population databases (rs120074162, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Tyr132*) in the DYM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYM are known to be pathogenic (PMID: 12491225, 12554689, 18996921). - |
Dyggve-Melchior-Clausen syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2003 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at